Emaglin 10 mg (Tablet)
Unit Price: ৳ 25.00 (3 x 10: ৳ 750.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Empagliflozin |
| Company | Dbl pharmaceuticals ltd |
| Also available as |
Title
- Emaglin 10 mg Tablet
Categories
- Diabetes Medications
- Cardiovascular Medications
Description
- SGLT-2 inhibitor for type 2 diabetes mellitus
- Reduces risk of cardiovascular death in type 2 diabetes mellitus with established cardiovascular disease
Dosage
- 10 mg once daily
- Morning administration
- With or without food
- May be increased to 25 mg once daily in tolerant patients
- Correction of volume depletion recommended before initiation in some patients
Interaction
- Increased urine volume with diuretics
- Increased risk of hypoglycemia with insulin or insulin secretagogues
- Urinary glucose tests not recommended
- Unreliable 1,5-AG assay in assessing glycemic control
Contraindications
- History of serious hypersensitivity reaction to Empagliflozin or any of its ingredients
- Severe renal impairment
- End-stage renal disease
- Dialysis
Side Effects
- Urinary tract infections
- Female genital mycotic infections
- Dehydration
- Hypotension
- Weakness
- Dizziness
- Increased thirstiness
Pregnancy & Lactation
- Use during pregnancy if potential benefit justifies potential risk to fetus
- Not recommended during breastfeeding
- Inadequate studies in pregnant women
- Unknown excretion in human milk
Precautions & Warnings
- Assessment of renal function recommended prior to initiation
- Not initiated in patients with eGFR less than 45 ml/min/1.73 m²
- No dose adjustment needed in patients with eGFR greater than or equal to 45 ml/min/1.73 m²
Overdose Effects
- Supportive measures recommended
- Hemodialysis effectiveness not studied
Therapeutic Class
- Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors
Storage Conditions
- Cool & dry place below 30°C
- Protected from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C23H27ClO7
- Chemical Structure Image
Common Questions
- Indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes mellitus
- Commonly used to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease
- Unsafe to use during pregnancy
- Unsafe to use during breastfeeding
- Cautious use in patients with underlying kidney disease
- No dose adjustment needed for patients with mild to moderate liver disease
- Used alone or together with other diabetes medicines to control blood sugar and avoid long-term complications
- May cause dehydration or increased urination, drink plenty of water and stay hydrated
- May cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if a meal is delayed or missed
- May cause genital fungal and/or urinary tract infections, practice good hygiene
- Regular blood sugar monitoring recommended
- Immediate doctor notification for specific symptoms
Usability Features
- Can be used alone or together with other diabetes medicines
- Requires regular blood sugar monitoring
Technical Specifications
- Molecular Formula: C23H27ClO7
Material
- Empagliflozin
Design Elements
- Chemical Structure Image